CALCULATE YOUR SIP RETURNS

Best Short-Term Stocks in January 2025: Trent, HCL Tech, and More Based on 6-Month Returns

Updated on: Jan 6, 2025, 6:18 PM IST
Explore the top short-term stocks in January 2025, selected based on their strong 6-month returns, including companies like Trent, HCL Tech, and more.
Best Short-Term Stocks in January 2025: Trent, HCL Tech, and More Based on 6-Month Returns
ShareShare on 1Share on 2Share on 3Share on 4Share on 5

In the fast-paced world of stock trading, short-term investments often present opportunities to capitalise on recent market trends. Focusing on stocks with strong performance over 6 months can offer insights into potential short-term growth.

In this article, we explore some of the best short-term stocks for January 2025, based on their 6-month returns, while also providing an overview of factors to consider when investing.

 

Best Short-Term Stocks in January 2025 – Based on 6 Month Returns

Name Sub-Sector Market Cap (₹ Cr) ↓6M Return (%) 1Y Return (%) PE Ratio
Trent Ltd Retail – Apparel 2,59,779.57 33.01 138.94 174.72
HCL Technologies Ltd IT Services and Consulting 5,26,789.43 31.44 35.4 33.55
Sun Pharmaceutical Industries Ltd Pharmaceuticals 4,43,792.99 20.58 42.43 46.34
Infosys Ltd IT Services and Consulting 8,03,036.44 19.13 30.12 30.61
Apollo Hospitals Enterprise Ltd Hospitals and Diagnostic Centres 1,04,939.08 17.85 26.53 116.78
Tech Mahindra Ltd IT Services and Consulting 1,65,361.18 14.17 35.79 70.13
Eicher Motors Ltd Trucks and Buses 1,45,584.90 13.18 36.61 36.39
Bharti Airtel Ltd Telecom Services 9,56,387.80 12.61 54.45 128.08
ITC Ltd FMCG – Tobacco 6,02,563.97 12.44 0.91 29.45
Mahindra and Mahindra Ltd Four Wheelers 3,82,446.47 10.86 92.75 33.94

Note: The list of best short-term stocks here is sourced from the Nifty 50 universe, sorted based on the 6-month year-to-date returns as of January 6, 2025.

 

Overview of the Best Short-Term Stocks in January 2025

  • Trent Ltd

Trent Ltd, a part of the Tata Group, is a leading Indian retail company that operates various retail chains, including Westside, Zudio, and Landmark.

For the quarter ending September 30, 2024, Trent Ltd reported a 46.9% year-on-year increase in net profit for Q2 FY25, reaching ₹355.06 crore, up from ₹228.06 crore. The company also saw a 39.3% rise in revenue, reaching ₹4,156.67 crore compared to ₹2,982.42 crore in the same quarter last year.

Key metrics:

  • Earning per Share (EPS): ₹41.82
  • Return On Equity (ROE): 43.95%

 

  • HCL Technologies Ltd

HCL Technologies Ltd is a leading global IT services and consulting company, offering solutions in digital, engineering, cloud, and software to help enterprises accelerate their digital transformation.

For the quarter ending September 30, 2024, HCLTech reported a net profit of ₹4,235 crore for Q2 FY25, marking an 11% year-on-year increase. The company’s revenue for the quarter stood at ₹28,862 crore, reflecting an 8.2% growth compared to the previous year.

Key metrics:

  • EPS: ₹57.86
  • ROE: 23.49%

 

  • Sun Pharmaceutical Industries Ltd

Sun Pharmaceutical Industries Ltd is the fourth largest global generic pharmaceutical company, founded in 1983. It offers over 2,000 products across more than 100 countries.

For the quarter ending September 30, 2024, Sun Pharma reported a 28% year-on-year increase in net profit, reaching ₹3,040 crore, surpassing expectations. Consolidated revenue grew by 9% to ₹13,291 crore, driven by strong market growth, particularly in the US.

Key metrics:

  • EPS: ₹39.91
  • ROE: 15.15%

 

  • Infosys Ltd

Infosys Ltd is a global leader in next-generation digital services and consulting, established in 1981. It has grown from a US$250 investment to become a US$18.8 billion company.

For the quarter ending September 30, 2024, Infosys reported a 2.2% rise in net profit to ₹6,506 crore and a 4.25% increase in revenues to ₹40,986 crore for Q2 FY25, compared to the previous quarter.

Key metrics:

  • EPS: ₹63.39
  • ROE: 31.94%

 

  • Apollo Hospitals Enterprise Ltd

Apollo Hospitals Enterprise Ltd, established in 1983, is India’s first corporate hospital and a pioneer in private healthcare.

For the quarter ending September 30, 2024, Apollo Hospitals reported a 63% increase in its net profit, reaching ₹379 crore in Q2 FY25, up from ₹233 crore in the same period last year. Its revenue from operations grew by 15% to ₹5,589 crore, driven by improved performance across all segments.

Key metrics:

  • EPS: ₹62.50
  • ROE: 12.97%

 

Key Considerations Before Investing in the Short-Term Stocks

  • Market Volatility

Short-term stocks are highly sensitive to market fluctuations. It’s essential to monitor market trends and understand that prices can change rapidly due to economic, political, or company-specific news.

  • Liquidity

Ensure the stock has sufficient trading volume. Stocks with low liquidity may be difficult to buy or sell at desired prices, leading to potential losses or missed opportunities.

  • Technical Analysis

Short-term investments often rely on technical analysis to predict price movements. Understanding chart patterns, trends, and technical indicators can help you make informed decisions.

  • Earnings Reports and News

Stock prices can be significantly affected by a company’s earnings reports, product launches, or news. It’s important to stay updated on the company’s financial performance and any relevant news events.

  • Risk Tolerance

Short-term stocks can offer higher returns but come with greater risk. Assess your risk tolerance and ensure you’re prepared for potential volatility in the short-term horizon.

Conclusion

Short-term investments can be a great option for reaching specific financial goals in the near future. However, it’s crucial to clearly define your investment objectives and understand your risk appetite before diving in. Furthermore, thoroughly assess the company’s performance, financial stability, and growth prospects to make well-informed decisions that align with your goals.

 

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

 

Published on: Jan 6, 2025, 6:18 PM IST

We're Live on WhatsApp! Join our channel for market insights & updates

Open Free Demat Account!

Join our 2 Cr+ happy customers

+91
Enjoy Zero Brokerage on Equity Delivery
4.4 Cr+DOWNLOADS
Enjoy ₹0 Account Opening Charges

Get the link to download the App

Send App Link
Get it on Google PlayDownload on the App Store
Open Free Demat Account!
Join our 2 Cr+ happy customers